Free shipping on orders over $95Buy one with 1% offer on sale price
Zoom the image with the mouse
Teratogenicity Testing: Methods and Protocols
ISBN:
9781071636244
List Price:
$279.99
Share:
Special Offers Available
Free shipping on orders over $95Buy one with 1% offer on sale priceBuy New
We can help you leverage the power of books
Customer Service
Connect with a dedicated account manager who is there every step of the way.
Price Match Guarantee
If you see better pricing elsewhere on your desired quantity, we will price match so you can be sure to get the best pricing.
Free Shipping
Enjoy free ground shipping on your order of $95 or more!
Brand New Guarantee
We only sell books that are brand new and protect that with a guarantee.
Customization
From author signatures to marketing inserts, custom packaging to brand stickers, we can help take your book marketing to the next level.
Details
This fully updated volume collects laboratory techniques and tests to assess the risks to embryo-fetal development from drug exposure during early developmental stages. Beginning with a section detailing basic principles of teratogenicity, the book continues with application of in vitro models for teratogenic screening to predict toxicity in embryonic animals and humans, as well as a variety of well-established in vivo animal model tests, which offer solutions for evaluating the efficacy and the teratogenicity of compounds in preclinical trials before human safety testing. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step and readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
Authoritative and practical, Teratogenicity Testing: Methods and Protocols, Second Edition serves as an ideal guide to tests that can be performed in cells, organs, tissues, and animal models for evaluating toxicity and/or safety of compounds in early developmental stages with the goal of estimating, preventing, or minimizing the teratogenic potential of drugs.
